BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21763111)

  • 1. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets.
    Hufbauer M; Lazić D; Reinartz M; Akgül B; Pfister H; Weissenborn SJ
    J Dermatol Sci; 2011 Oct; 64(1):7-15. PubMed ID: 21763111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
    Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice.
    Hufbauer M; Lazić D; Akgül B; Brandsma JL; Pfister H; Weissenborn SJ
    Virology; 2010 Aug; 403(2):128-36. PubMed ID: 20451232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice.
    De Andrea M; Rittà M; Landini MM; Borgogna C; Mondini M; Kern F; Ehrenreiter K; Baccarini M; Marcuzzi GP; Smola S; Pfister H; Landolfo S; Gariglio M
    Cancer Res; 2010 Oct; 70(20):7938-48. PubMed ID: 20876801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.
    Pfefferle R; Marcuzzi GP; Akgül B; Kasper HU; Schulze F; Haase I; Wickenhauser C; Pfister H
    J Invest Dermatol; 2008 Sep; 128(9):2310-5. PubMed ID: 18401427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
    Babashah S; Soleimani M
    Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice.
    Lazić D; Alborzi F; Marcuzzi GP; Angel P; Hess J; Pfister H; Akgül B
    J Dermatol Sci; 2011 May; 62(2):84-90. PubMed ID: 21458245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
    Akgül B; Pfefferle R; Marcuzzi GP; Zigrino P; Krieg T; Pfister H; Mauch C
    Exp Dermatol; 2006 Jan; 15(1):35-42. PubMed ID: 16364029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of conserved microRNAs from skin and mucosal human papillomaviruses.
    Gu W; An J; Ye P; Zhao KN; Antonsson A
    Arch Virol; 2011 Jul; 156(7):1161-71. PubMed ID: 21442230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding.
    Marcuzzi GP; Hufbauer M; Kasper HU; Weißenborn SJ; Smola S; Pfister H
    J Gen Virol; 2009 Dec; 90(Pt 12):2855-2864. PubMed ID: 19692543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
    Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
    Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis.
    Hufbauer M; Cooke J; van der Horst GT; Pfister H; Storey A; Akgül B
    Mol Cancer; 2015 Oct; 14():183. PubMed ID: 26511842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer.
    Lai KW; Koh KX; Loh M; Tada K; Subramaniam MM; Lim XY; Vaithilingam A; Salto-Tellez M; Iacopetta B; Ito Y; Soong R;
    Eur J Cancer; 2010 May; 46(8):1456-63. PubMed ID: 20176475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic animal models of human papillomavirus-dependent disease (Review).
    Eckert RL; Crish JF; Balasubramanian S; Rorke EA
    Int J Oncol; 2000 May; 16(5):853-70. PubMed ID: 10762621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.
    Meyers JM; Uberoi A; Grace M; Lambert PF; Munger K
    PLoS Pathog; 2017 Jan; 13(1):e1006171. PubMed ID: 28107544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired microRNA processing enhances cellular transformation and tumorigenesis.
    Kumar MS; Lu J; Mercer KL; Golub TR; Jacks T
    Nat Genet; 2007 May; 39(5):673-7. PubMed ID: 17401365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen.
    Wang Q; Li DC; Li ZF; Liu CX; Xiao YM; Zhang B; Li XD; Zhao J; Chen LP; Xing XM; Tang SF; Lin YC; Lai YD; Yang P; Zeng JL; Xiao Q; Zeng XW; Lin ZN; Zhuang ZX; Zhuang SM; Chen W
    Oncogene; 2011 Sep; 30(36):3875-86. PubMed ID: 21460851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-modulated autophagic signaling networks in cancer.
    Fu LL; Wen X; Bao JK; Liu B
    Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.